SERPINE1 and type 2 diabetes mellitus: PAI-1 expression is elevated in visceral obesity, insulin resistance (IR) and hypertriglyceridemia, and its levels appears to predict risk for future development of both type 2 diabetes (T2D) and CVD [31].